Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Extended-Release Buprenorphine Treatments for Opioid Use Disorder

April 18, 2024
12:00 pm–1:00 pm ET

This training is designed to provide healthcare teams with information on all the available FDA-approved monthly/weekly injectable buprenorphine formulations used to treat opioid use disorder, as well as how to incorporate them into clinical practice.

Please read the Accreditation Information section of this page to learn about the requirements for receiving credit or a certificate of completion.

Register now

Virtual meeting

Via Zoom

Description

This training is designed to provide healthcare teams with information on all the available FDA-approved monthly/weekly injectable buprenorphine formulations used to treat opioid use disorder, as well as how to incorporate them into clinical practice.

Topics include the pharmacology and side effects of injectable buprenorphine formulations, storage, administration and patient selection processes, dosage, initiation and maintenance for patients using weekly and monthly injectable doses, and the workflows and administrative tasks involved in implementing injectable buprenorphine in healthcare settings.

NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit. 

Intended audience

Physicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend.

Speakers

Jessica Kemp, RN, CARN Emery Marcus, MSN, FNP-C, PMHNP-BC, CARN-AP

Objectives

  1. Explain the pharmacology and side effects of injectable buprenorphine formulations.
  2. Recall processes of patient selection, storage, and administration of injectable buprenorphine.
  3. Develop a basic understanding of dosing, initiation, and maintenance using weekly and monthly injectable buprenorphine. 
  4. Identify workflows and administrative requirements for implementing injectable buprenorphine within healthcare settings.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

  1. Register for training.
  2. Arrive/log into the training no more than 10 minutes after designated start time for program.
  3. Identify yourself by typing your full name into the chat and ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
  4. Be present through the end of the activity (i.e. until the designated end time of training).
  5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for CME, Nursing and Social Work

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Nursing Contact Hours: 1.00 contact hours, of which 1.00 are eligible for pharmacology credit.

Social Work

As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Grayken Center for Addiction TTA is approved to offer LADC/CADCs and recovery coaches who complete this course 1.00 general continuing education credits.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2024 Boston Medical Center. All rights reserved. Site by Root802.